The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Frailty Study of Older Adults Getting Chemotherapy and Radiation Therapy
Official Title: A Pilot Trial of Frailty Assessment in Older Adults (Age 70 >) Requiring Concurrent Chemotherapy Plus Radiation Therapy for Cancer (CTRC# 12-22)
Study ID: NCT01808833
Brief Summary: The investigators hypothesize that frailty assessment prior to concurrent chemotherapy and radiation therapy in the elderly will predict treatment-related toxicity and morbidity and that such assessment at serial time points will help improve treatment and outcomes for these patients.
Detailed Description:
Minimum Age: 70 Years
Eligible Ages: OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Cancer Therapy and Research Center at UTHSCSA, San Antonio, Texas, United States
Name: Anand Karnad, MD
Affiliation: University of Texas
Role: PRINCIPAL_INVESTIGATOR